Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 29-Aug-23 4:08 PM View:  | Suri Anish President and CSO | Cue Biopharma, Inc. (CUE) | 25-Aug-23 | Private Purchase | 4,000 | $2.76 | $11,040.00 | 3% 131.64K to 135.64K | |
| 16-Aug-23 4:07 PM View: | Passeri Daniel R CHIEF EXECUTIVE OFFICER Director | Cue Biopharma, Inc. (CUE) | 14-Aug-23 | Private Purchase | 3,000 | $2.86 | $8,580.00 | 2% 131.58K to 134.58K | |
| 27-Mar-23 4:05 PM View: | Kiener Peter A Director | Cue Biopharma, Inc. (CUE) | 23-Mar-23 | Option Exercise | 9,682 | $2.86 | $27,690.50 | 100% 0 to 9.68K | |
| 27-Mar-23 4:05 PM View: | Kiener Peter A Director | Cue Biopharma, Inc. (CUE) | 23-Mar-23 | Option Sale | 9,325 | $3.28 | $30,586.00 | (96%) 9.68K to 0.36K | |
| 23-Aug-22 4:03 PM View: | Millar Kerri-Ann CHIEF FINANCIAL OFFICER | Cue Biopharma, Inc. (CUE) | 22-Aug-22 | Payment of Exercise | 2,828 | $3.05 | $8,625.40 | (17%) 17.14K to 14.31K | |
| 23-Aug-22 4:03 PM View: | Millar Kerri-Ann CHIEF FINANCIAL OFFICER | Cue Biopharma, Inc. (CUE) | 21-Aug-22 | Option Exercise | 6,667 | -- | -- | 64% 10.47K to 17.14K | |
| 16-Jun-22 4:01 PM View: | Gray Cameron Director | Cue Biopharma, Inc. (CUE) | 14-Jun-22 | Exercise (in-the money or at-the-money) | 61,111 | $2.70 | $165,000.00 | 9% 677.5K to 738.61K | |
| 16-Jun-22 4:01 PM View: | Gray Cameron Director | Cue Biopharma, Inc. (CUE) | 14-Jun-22 | Payment of Exercise | 51,562 | $3.20 | $164,998.00 | (7%) 738.61K to 687.05K | |
| 31-May-22 4:06 PM View: | Morich Frank Director | Cue Biopharma, Inc. (CUE) | 27-May-22 | Private Purchase | 28,000 | $3.75 | $105,000.00 | 100% 0 to 28.0K | |
| 25-May-22 9:09 AM View: | Fletcher Aaron G.L. Director | Cue Biopharma, Inc. (CUE) | 24-May-22 | Purchase | 55,000 | $3.34 | $183,700.00 | 5% 1.06M to 1.11M | |
| 25-May-22 9:09 AM View: | Fletcher Aaron G.L. Director | Cue Biopharma, Inc. (CUE) | 23-May-22 | Private Purchase | 150,000 | $3.52 | $528,000.00 | 17% 908.87K to 1.06M | |
| 04-Apr-22 5:28 PM View: | Fletcher Aaron G.L. Director | Cue Biopharma, Inc. (CUE) | 31-Mar-22 | Private Purchase | 735,000 | $4.76 | $3,498,600.00 | 423% 173.87K to 908.87K | |
| 04-Apr-22 5:29 PM View: | Passeri Daniel R CHIEF EXECUTIVE OFFICER Director | Cue Biopharma, Inc. (CUE) | 31-Mar-22 | Payment of Exercise | 32,122 | $4.88 | $156,755.00 | (18%) 173.7K to 141.58K | |
| 04-Apr-22 5:29 PM View: | Passeri Daniel R CHIEF EXECUTIVE OFFICER Director | Cue Biopharma, Inc. (CUE) | 31-Mar-22 | Option Exercise | 75,000 | -- | -- | 76% 98.7K to 173.7K | |
| 04-Apr-22 5:29 PM View: | Passeri Daniel R CHIEF EXECUTIVE OFFICER Director | Cue Biopharma, Inc. (CUE) | 31-Mar-22 | Gift | 10,000 | -- | -- | (7%) 141.58K to 131.58K | |
| 04-Apr-22 5:31 PM View: | Suri Anish President and CSO | Cue Biopharma, Inc. (CUE) | 31-Mar-22 | Option Exercise | 16,668 | -- | -- | 18% 94.04K to 110.71K | |
| 04-Apr-22 5:31 PM View: | Suri Anish President and CSO | Cue Biopharma, Inc. (CUE) | 31-Mar-22 | Payment of Exercise | 7,068 | $4.88 | $34,491.80 | (6%) 110.71K to 103.64K | |
| 17-Nov-21 10:00 PM View: | Kiener Peter A Director | Cue Biopharma, Inc. (CUE) | 16-Nov-21 | Option Exercise | 1,361 | $2.86 | $3,892.46 | 100% 0 to 1.36K | |
| 17-Nov-21 10:00 PM View: | Kiener Peter A Director | Cue Biopharma, Inc. (CUE) | 16-Nov-21 | Market Option Sale (Planned) | 1,361 | $18.02 | $24,525.20 | (100%) 1.36K to 0 | |
| 17-Nov-21 10:00 PM View: | Kiener Peter A Director | Cue Biopharma, Inc. (CUE) | 15-Nov-21 | Market Option Sale (Planned) | 18,815 | $17.92 | $337,165.00 | (100%) 18.82K to 0 | |
| 17-Nov-21 5:00 PM View: | Suri Anish President and CSO | Cue Biopharma, Inc. (CUE) | 15-Nov-21 | Option Exercise | 8,000 | $8.26 | $66,080.00 | 9% 94.04K to 102.04K | |
| 17-Nov-21 10:00 PM View: | Kiener Peter A Director | Cue Biopharma, Inc. (CUE) | 15-Nov-21 | Option Exercise | 18,815 | $2.86 | $53,810.90 | 100% 0 to 18.82K | |
| 17-Nov-21 5:00 PM View: | Suri Anish President and CSO | Cue Biopharma, Inc. (CUE) | 15-Nov-21 | Market Option Sale (Planned) | 8,000 | $18.05 | $144,400.00 | (8%) 102.04K to 94.04K | |
| 15-Nov-21 5:00 PM View: | Suri Anish President and CSO | Cue Biopharma, Inc. (CUE) | 11-Nov-21 | Option Exercise | 20,000 | $6.42 | $128,400.00 | 21% 94.04K to 114.04K | |
| 15-Nov-21 5:00 PM View: | Suri Anish President and CSO | Cue Biopharma, Inc. (CUE) | 11-Nov-21 | Market Option Sale (Planned) | 20,000 | $15.07 | $301,354.00 | (18%) 114.04K to 94.04K | |
| 08-Oct-21 4:00 PM View: | Suri Anish President and CSO | Cue Biopharma, Inc. (CUE) | 06-Oct-21 | Payment of Exercise | 14,134 | $12.97 | $183,318.00 | (13%) 108.17K to 94.04K | |
| 08-Oct-21 4:00 PM View: | Suri Anish President and CSO | Cue Biopharma, Inc. (CUE) | 03-Oct-21 | Option Exercise | 33,334 | -- | -- | 45% 74.84K to 108.17K | |
| 05-Oct-21 7:21 PM View: | Millar Kerri-Ann CHIEF FINANCIAL OFFICER | Cue Biopharma, Inc. (CUE) | 01-Oct-21 | Option Exercise | 1,251 | $7.50 | $9,382.50 | 12% 10.47K to 11.72K | |
| 05-Oct-21 7:21 PM View: | Millar Kerri-Ann CHIEF FINANCIAL OFFICER | Cue Biopharma, Inc. (CUE) | 01-Oct-21 | Market Option Sale (Planned) | 1,251 | $14.21 | $17,782.80 | (11%) 11.72K to 10.47K | |
| 08-Oct-21 4:00 PM View: | Passeri Daniel R CHIEF EXECUTIVE OFFICER Director | Cue Biopharma, Inc. (CUE) | 30-Sep-21 | Payment of Exercise | 31,677 | $14.57 | $461,534.00 | (24%) 130.38K to 98.7K | |
| 08-Oct-21 4:00 PM View: | Passeri Daniel R CHIEF EXECUTIVE OFFICER Director | Cue Biopharma, Inc. (CUE) | 30-Sep-21 | Option Exercise | 75,000 | -- | -- | 135% 55.38K to 130.38K | |
| 27-Sep-21 4:30 PM View: | Passeri Daniel R CHIEF EXECUTIVE OFFICER Director | Cue Biopharma, Inc. (CUE) | 24-Sep-21 | Market Purchase | 3,400 | $14.72 | $50,051.40 | 7% 51.98K to 55.38K | (2%) |
| 27-Sep-21 4:30 PM View: | Suri Anish President and CSO | Cue Biopharma, Inc. (CUE) | 23-Sep-21 | Market Option Sale (Planned) | 20,000 | $15.23 | $304,646.00 | (21%) 94.84K to 74.84K | |
| 27-Sep-21 4:30 PM View: | Suri Anish President and CSO | Cue Biopharma, Inc. (CUE) | 23-Sep-21 | Option Exercise | 20,000 | $6.42 | $128,400.00 | 27% 74.84K to 94.84K | |
| 05-Oct-21 7:21 PM View: | Millar Kerri-Ann CHIEF FINANCIAL OFFICER | Cue Biopharma, Inc. (CUE) | 23-Aug-21 | Option Exercise | 6,667 | -- | -- | 116% 5.77K to 12.43K | |
| 05-Oct-21 7:21 PM View: | Millar Kerri-Ann CHIEF FINANCIAL OFFICER | Cue Biopharma, Inc. (CUE) | 23-Aug-21 | Payment of Exercise | 1,961 | -- | -- | (16%) 12.43K to 10.47K | |
| 17-Mar-21 4:00 PM View: | Pienta Kenneth Chief Medical Officer | Cue Biopharma, Inc. (CUE) | 16-Mar-21 | Option Exercise | 439 | $5.00 | $2,195.00 | 22% 2.0K to 2.44K | |
| 17-Mar-21 4:00 PM View: | Pienta Kenneth Chief Medical Officer | Cue Biopharma, Inc. (CUE) | 16-Mar-21 | Market Option Sale (Planned) | 439 | $15.09 | $6,625.65 | (18%) 2.44K to 2.0K | |
| 17-Mar-21 4:00 PM View: | Pienta Kenneth Chief Medical Officer | Cue Biopharma, Inc. (CUE) | 15-Mar-21 | Option Exercise | 13,000 | $5.00 | $65,000.00 | 650% 2.0K to 15.0K | |
| 17-Mar-21 4:00 PM View: | Pienta Kenneth Chief Medical Officer | Cue Biopharma, Inc. (CUE) | 15-Mar-21 | Market Option Sale (Planned) | 13,000 | $15.10 | $196,269.00 | (87%) 15.0K to 2.0K | |
| 18-Feb-21 8:44 PM View: | Pienta Kenneth Chief Medical Officer | Cue Biopharma, Inc. (CUE) | 17-Feb-21 | Option Exercise | 4,274 | $4.36 | $18,630.80 | 214% 2.0K to 6.27K | |
| 18-Feb-21 8:44 PM View: | Pienta Kenneth Chief Medical Officer | Cue Biopharma, Inc. (CUE) | 17-Feb-21 | Market Option Sale (Planned) | 4,274 | $15.06 | $64,345.10 | (68%) 6.27K to 2.0K | |
| 18-Feb-21 8:44 PM View: | Pienta Kenneth Chief Medical Officer | Cue Biopharma, Inc. (CUE) | 16-Feb-21 | Option Exercise | 16,000 | $2.86 | $45,760.00 | 800% 2.0K to 18.0K | |
| 18-Feb-21 8:44 PM View: | Pienta Kenneth Chief Medical Officer | Cue Biopharma, Inc. (CUE) | 16-Feb-21 | Market Option Sale (Planned) | 16,000 | $15.15 | $242,422.00 | (89%) 18.0K to 2.0K | |
| 22-Jan-21 4:33 PM View: | Pienta Kenneth Chief Medical Officer | Cue Biopharma, Inc. (CUE) | 20-Jan-21 | Market Purchase | 2,720 | $15.07 | $40,979.50 | 136% 2.0K to 4.72K | (9%) |
| 01-Feb-21 10:00 PM View: | Gray Cameron Director | Cue Biopharma, Inc. (CUE) | 02-Dec-20 | Gift | 596,200 | -- | -- | 88% 677.5K to 1.27M | |
| 01-Feb-21 10:00 PM View: | Gray Cameron Director | Cue Biopharma, Inc. (CUE) | 02-Dec-20 | Gift | 596,200 | -- | -- | (47%) 1.27M to 677.5K | |
| 25-Nov-20 4:09 PM View: | Fletcher Aaron G.L. Director | Cue Biopharma, Inc. (CUE) | 24-Nov-20 | Market Purchase | 6,548 | $12.64 | $82,775.90 | 4% 167.32K to 173.87K | 3% |
| 06-Oct-20 5:08 PM View: | Suri Anish President and CSO | Cue Biopharma, Inc. (CUE) | 05-Oct-20 | Payment of Exercise | 9,800 | $16.30 | $159,740.00 | (14%) 67.89K to 58.09K | 20% |
| 06-Oct-20 5:08 PM View: | Suri Anish President and CSO | Cue Biopharma, Inc. (CUE) | 03-Oct-20 | Option Exercise | 33,333 | -- | -- | 96% 34.56K to 67.89K |
